Lorence H. Kim's Insider Trades & SAST Disclosures
Lorence H. Kim's most recent trade in Cencora Inc. was a trade of 789 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Lorence H. Kim.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cencora Inc. | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 789 | 3,524 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 70,500 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 69,948 (0%) | 0% | 0 | Common Stock | |
| Cencora Inc. | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 843 | 2,735 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 65,700 (0%) | 0% | 0 | Common Stock | |
| Cencora Inc. | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,334 | 1,892 (0%) | 0% | - | Common Stock | |
| Cencora Inc. | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 558 | 558 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Jul 2022 | 50,000 | 60,500 (0%) | 0% | 20 | 1,000,000 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 36,800 | 36,800 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 10,500 | 10,500 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.30 per share. | 02 Jun 2020 | 241,000 | 1,202,510 (0%) | 0% | 58.3 | 14,050,300 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 02 Jun 2020 | 96,660 | 1,443,510 (0%) | 0% | 19.2 | 1,851,039 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2020 | 96,660 | 0 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 02 Jun 2020 | 78,309 | 1,280,819 (0%) | 0% | 14.2 | 1,113,554 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2020 | 78,309 | 587,735 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2020 | 66,031 | 578,372 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.15 per share. | 02 Jun 2020 | 66,031 | 1,346,850 (0%) | 0% | 19.2 | 1,264,494 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.13 per share. | 27 May 2020 | 241,000 | 1,202,510 (0%) | 0% | 51.1 | 12,322,330 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 27 May 2020 | 222,365 | 1,424,875 (0%) | 0% | 14.2 | 3,162,030 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2020 | 222,365 | 666,044 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.21 per share. | 27 May 2020 | 18,635 | 1,443,510 (0%) | 0% | 12.2 | 227,533 | Common Stock |
| Moderna Inc | Lorence H. Kim | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2020 | 18,635 | 55,909 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges